Pharmafile Logo

Event Logistics

- PMLiVE

FDA approves first cholera vaccine in US

PaxVax’s oral vaccine Vaxchora will be launched by September

- PMLiVE

Agendia appoints chairman of medical advisory board

Dr Gabriel Hortobagyi takes on the lead advisor role

- PMLiVE

A rare opportunity

Sobi’s Neil Dugdale on how the UK’s approach to rare diseases is changing

- PMLiVE

Primex Pharma appoints head of global marketing

Alan Knox will join the firm’s executive team from 1 July

- PMLiVE

Healthcare and the digital revolution

How can medtech companies capitalise on this digital transformation?

Lucid

Future-proofing with a comprehensive talent development strategy

Lucid Group is an award-winning group of specialist medical education companies. Over the years, Lucid has developed a strong culture of empowerment, thought-leadership, entrepreneurship and passion to improve outcomes for...

Lucid Group Communications Limited

“Most eye-catching” agency Pegasus scoops the ‘EMEA Healthcare PR Consultancy of the Year’ at Sabre Awards

Pegasus wins the prestigious “EMEA Healthcare PR Consultancy of the Year” award at the recent Sabre Awards in Berlin, organised by The Holmes Report.

Inizio

- PMLiVE

European pharma considering medicine pricing shakeup

EFPIA will later this month discuss proposals for a value-based pricing system

Deal Watch May 2016

Novartis, Quintiles and Sanofi are among those featured in this month’s round-up of pharma deal activity

- PMLiVE

Merck buys cough drug developer Afferent for $1.25bn

Gains access to pipeline with potential for development in ‘neurogenic’ indications

- PMLiVE

FDA panel backs Pfizer and Teva abuse-resistant painkillers

Recommends long-acting opioid analgesics Troxyca ER and Vantrela ER for approval

- PMLiVE

Eric Rhodes becomes CEO of ERS Genomics

Succeeds the company’s founder Shaun Foy in the role

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links